American Century Companies’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$837K Sell
158,869
-935
-0.6% -$4.92K ﹤0.01% 2457
2026
Q1
$668K Sell
159,804
-1,266
-0.8% -$6.09K ﹤0.01% 2446
2025
Q4
$775K Buy
161,070
+8,521
+6% +$41.2K ﹤0.01% 2395
2025
Q3
$772K Buy
152,549
+23,155
+18% +$102K ﹤0.01% 2383
2025
Q2
$521K Buy
129,394
+1,932
+2% +$6.29K ﹤0.01% 2514
2025
Q1
$348K Buy
127,462
+17,514
+16% +$62.8K ﹤0.01% 2631
2024
Q4
$467K Buy
109,948
+10,726
+11% +$40.8K ﹤0.01% 2538
2024
Q3
$292K Buy
99,222
+15,972
+19% +$50.8K ﹤0.01% 2655
2024
Q2
$290K Buy
83,250
+14,372
+21% +$47.9K ﹤0.01% 2646
2024
Q1
$196K Buy
68,878
+17,838
+35% +$55K ﹤0.01% 2765
2023
Q4
$180K Buy
51,040
+14,541
+40% +$41.7K ﹤0.01% 2723
2023
Q3
$94.5K Buy
36,499
+24,968
+217% +$87.7K ﹤0.01% 2726
2023
Q2
$45.4K Buy
+11,531
New +$36.6K ﹤0.01% 2770

Other funds holding SRTA

American Century Companies's SRTA Position: Q2 2026 in Review

American Century Companies reduced its Strata Critical Medical Inc (SRTA) stake by 0.59% in Q2 2026, selling an estimated $4.92K and leaving 158,869 shares worth $837K. The position accounts for ﹤0.01% of the portfolio, ranked #2457.

American Century Companies first reported a position in SRTA in Q2 2023 and has held it in 13 quarters since. 94 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • American Century Companies held 158,869 shares of Strata Critical Medical Inc worth $837K as of Q2 2026.
  • American Century Companies sold 935 Strata Critical Medical Inc shares in Q2 2026, an estimated $4.92K.
  • Strata Critical Medical Inc made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2457 holding.
  • American Century Companies first reported a position in Strata Critical Medical Inc in Q2 2023 and has held it in 13 quarters since.
  • 94 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.